[Newsdesk] Research in brief
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00129-5/fulltext?rss=yes
A phase 2 randomised trial compared a full or half dose of a live-attenuated chikungunya vaccine (VLA1553) versus an active control (meningococcal vaccine) in 304 children aged 1–11 years in Honduras and the Dominican Republic. Up to 14 days after vaccination, there were no significant between-group differences in incidence or severity of solicited adverse events (AEs). The most common unsolicited AEs through 28 days after vaccination were infections and infestations, occurring in 10·0–20·5% of participants.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00129-5/fulltext?rss=yes
A phase 2 randomised trial compared a full or half dose of a live-attenuated chikungunya vaccine (VLA1553) versus an active control (meningococcal vaccine) in 304 children aged 1–11 years in Honduras and the Dominican Republic. Up to 14 days after vaccination, there were no significant between-group differences in incidence or severity of solicited adverse events (AEs). The most common unsolicited AEs through 28 days after vaccination were infections and infestations, occurring in 10·0–20·5% of participants.
❤3👍1
Enhanced Detection of Coccidioides spp. Fungi from Environmental Samples Using Droplet Digital PCR
https://wwwnc.cdc.gov/eid/article/32/4/25-1146_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1146_article
Emerging Infectious Diseases journal
Enhanced Detection of <em>Coccidioides</em> spp. Fungi from Environmental Samples Using Droplet Digital PCR
Detection of <em>Coccidioides</em> spp. Fungi Using ddPCR
Confirming ERVEBO Vaccination to Support Ebola Virus Surveillance
https://wwwnc.cdc.gov/eid/article/32/4/25-1906_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1906_article
Emerging Infectious Diseases journal
Confirming ERVEBO Vaccination to Support Ebola Virus Surveillance
ERVEBO Vaccination to Support Ebola Surveillance
Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus Infection in Humans and Domestic Ruminants, Democratic Republic of the Congo
https://wwwnc.cdc.gov/eid/article/32/4/25-0969_article
https://wwwnc.cdc.gov/eid/article/32/4/25-0969_article
Emerging Infectious Diseases journal
Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus Infection in Humans and Domestic Ruminants, Democratic Republic of the…
Who is this person and what did she accomplish?
https://wwwnc.cdc.gov/eid/article/32/4/25-1083_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1083_article
Emerging Infectious Diseases journal
Who is this person and what did she accomplish?
Photo Quiz
Anopheles stephensi [ә-nah′-fuhl-ēz ste′-fen-zī]
https://wwwnc.cdc.gov/eid/article/32/4/24-1933_article
https://wwwnc.cdc.gov/eid/article/32/4/24-1933_article
Emerging Infectious Diseases journal
<em>Anopheles stephensi</em> [ә-nah′-fuhl-ēz ste′-fen-zī]
Geographically Distinct Circulation of Genotype II and III St. Louis Encephalitis Virus, Texas, USA, 2009–2024
https://wwwnc.cdc.gov/eid/article/32/4/25-0934_article
https://wwwnc.cdc.gov/eid/article/32/4/25-0934_article
Emerging Infectious Diseases journal
Geographically Distinct Circulation of Genotype II and III St. Louis Encephalitis Virus, Texas, USA, 2009–2024
Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023–2024
https://wwwnc.cdc.gov/eid/article/32/4/25-1711_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1711_article
Emerging Infectious Diseases journal
Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023–2024
Malaria Drug Resistance, Burundi, 2023–2024
Evaluation of Effectiveness of Autocidal Gravid Ovitraps for Preventing Zika Virus Infection, Puerto Rico, USA
https://wwwnc.cdc.gov/eid/article/32/4/25-1206_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1206_article
Emerging Infectious Diseases journal
Evaluation of Effectiveness of Autocidal Gravid Ovitraps for Preventing Zika Virus Infection, Puerto Rico, USA
Gravid Ovitraps for Preventing ZIKV Infection
Tropism and Replication Competence of Cattle Influenza A(H5N1) Genotype B3.13 Virus in Human Bronchus and Lung Tissue
https://wwwnc.cdc.gov/eid/article/32/5/25-1926_article
https://wwwnc.cdc.gov/eid/article/32/5/25-1926_article
Emerging Infectious Diseases journal
Tropism and Replication Competence of Cattle Influenza A(H5N1) Genotype B3.13 Virus in Human Bronchus and Lung Tissue
Influenza A(H5N1) B3.13 in Human Tissue
❤1
[Comment] Structural stigma: an urgent intervention priority in Africa
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00359-5/fulltext?rss=yes
Improved access to antiretroviral therapy (ART) for people with HIV has greatly affected the trajectory of the global HIV pandemic, enabling people with HIV to lead long, healthy lives and curtailing the number of people who newly acquire HIV. Between 2000 and 2024, the number of people with HIV accessing ART globally increased from 370 000 to 31·6 million.1 Over the same period, the percentage of people with HIV accessing ART increased from 0% to 83% in Africa,2 a region that accounts for nearly two-thirds of the 40·8 million people with HIV worldwide.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00359-5/fulltext?rss=yes
Improved access to antiretroviral therapy (ART) for people with HIV has greatly affected the trajectory of the global HIV pandemic, enabling people with HIV to lead long, healthy lives and curtailing the number of people who newly acquire HIV. Between 2000 and 2024, the number of people with HIV accessing ART globally increased from 370 000 to 31·6 million.1 Over the same period, the percentage of people with HIV accessing ART increased from 0% to 83% in Africa,2 a region that accounts for nearly two-thirds of the 40·8 million people with HIV worldwide.
Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa
https://wwwnc.cdc.gov/eid/article/32/4/25-1407_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1407_article
Emerging Infectious Diseases journal
Accelerated Increase in <em>Candida auris</em> Bloodstream Infections during COVID-19 Pandemic, South Africa
<em>C. auris</em> Infections during COVID-19 Pandemic
❤2
Ecologic Investigative Strategies to Determine Human Plague Exposure Sites, United States, 1991–2018
https://wwwnc.cdc.gov/eid/article/32/4/25-1357_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1357_article
Emerging Infectious Diseases journal
Ecologic Investigative Strategies to Determine Human Plague Exposure Sites, United States, 1991–2018
Strategies to Determine Plague Exposure Sites, USA
Dengue Incidence, Seroprevalence, and Expansion Factors from Active Surveillance, Brazil, 2016–2021
https://wwwnc.cdc.gov/eid/article/32/4/25-0942_article
https://wwwnc.cdc.gov/eid/article/32/4/25-0942_article
Emerging Infectious Diseases journal
Dengue Incidence, Seroprevalence, and Expansion Factors from Active Surveillance, Brazil, 2016–2021
Dengue Active Surveillance, Brazil, 2016–2021
Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August–November 2024
https://wwwnc.cdc.gov/eid/article/32/5/25-1812_article
https://wwwnc.cdc.gov/eid/article/32/5/25-1812_article
Emerging Infectious Diseases journal
Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August–November 2024
Autochthonous Dengue, California, USA
Circulation Patterns, Genetic Diversity, and Public Health Implications of Enterovirus D68, Europe, 2014–2024
https://wwwnc.cdc.gov/eid/article/32/4/25-1022_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1022_article
Emerging Infectious Diseases journal
Circulation Patterns, Genetic Diversity, and Public Health Implications of Enterovirus D68, Europe, 2014–2024
Enterovirus D68 Circulation, Europe, 2014–2024
🔥1
Transmissibility and Disease Progression of Asymptomatic Mycobacterium tuberculosis Infection, Lima, Peru
https://wwwnc.cdc.gov/eid/article/32/4/25-1947_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1947_article
Emerging Infectious Diseases journal
Transmissibility and Disease Progression of Asymptomatic <em>Mycobacterium</em> <em>tuberculosis</em> Infection, Lima, Peru
Transmissibility of Asymptomatic <em>M. tuberculosis</em>
Whole-Genome Analysis of Treponema pallidum subsp. endemicum among Men Who Have Sex with Men, Japan, 2020–2023
https://wwwnc.cdc.gov/eid/article/32/4/25-1045_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1045_article
Emerging Infectious Diseases journal
Whole-Genome Analysis of <em>Treponema pallidum</em> subsp. <em>endemicum</em> among Men Who Have Sex with Men, Japan, 2020–2023
<em>T. pallidum</em> subsp. <em>endemicum</em> among MSM, Japan
Acute Febrile Illness Surveillance for Estimating Population Immunity, Dominican Republic, 2021
https://wwwnc.cdc.gov/eid/article/32/4/25-1205_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1205_article
Emerging Infectious Diseases journal
Acute Febrile Illness Surveillance for Estimating Population Immunity, Dominican Republic, 2021
Outbreak of Dengue Virus Serotype 3, Republic of the Marshall Islands, 2019–2021
https://wwwnc.cdc.gov/eid/article/32/4/25-1135_article
https://wwwnc.cdc.gov/eid/article/32/4/25-1135_article
Emerging Infectious Diseases journal
Outbreak of Dengue Virus Serotype 3, Republic of the Marshall Islands, 2019–2021
Dengue Virus Serotype 3, Marshall Islands